Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Additional Listing

19 Aug 2015 09:53

RNS Number : 4811W
Versarien PLC
19 August 2015
 

19 August 2015

 

Versarien plc

("Versarien" or the "Company")

 

Exercise of Share Options

 

Versarien (AIM: VRS), the advanced engineering materials group, is pleased to announce that, following the exercise of employee options, the Company has issued and allotted 110,150 new ordinary shares.

 

Accordingly, application has been made for the 110,150 new ordinary shares to be admitted to trading on AIM and it is expected that admission will take place on 24 August 2015.

 

The new ordinary shares will rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 105,631,514 ordinary shares.

 

 

For further information:

Versarien Plc

 

Neill Ricketts, Chief Executive Officer

Tel: +44 (0) 1594 888 622

 

Chris Leigh, Chief Financial Officer

www.versarien.com

 

Panmure Gordon

(Nominated Adviser and Broker)

Russell Cook

James Greenwood

Tel: +44 (0) 20 7886 2500

Media enquiries:

IFC Advisory

(Financial PR and IR)

Tim Metcalfe / Graham Herring / Heather Armstrong

Tel +44 (0)20 3053 8671

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISUKVWRVUAWARR
Date   Source Headline
29th Oct 20211:41 pmRNSResponse to Media Speculation
29th Oct 20217:00 amRNSInvestor Presentation
13th Oct 20217:00 amRNSAppointment of Non-executive Chairman
23rd Sep 20212:08 pmRNSResult of AGM
2nd Sep 202111:01 amRNSChange of Registered Address
27th Aug 20211:54 pmRNSNotice of AGM and Posting of Annual Report
11th Aug 20219:53 amRNSHolding(s) in Company
5th Aug 20217:00 amRNSPreliminary Results
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20217:00 amRNS£1.93m strategic investment by Graphene Lab
26th Feb 202110:16 amRNSInnovate UK Loan
9th Feb 20217:00 amRNSGraphene Enhanced Mask Update
22nd Jan 202111:05 amRNSDirector/PDMR Shareholding
21st Jan 20217:00 amRNSInterim Results
7th Jan 20217:00 amRNSAppointment of Chief Technology Officer
31st Dec 20207:00 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSHolding(s) in Company
23rd Dec 202012:31 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSAcquisition, Subscription & Sharing Agreement
24th Nov 20207:00 amRNS£1.95 million Development Agreement
23rd Nov 20204:39 pmRNSInterim Results Reporting Extension
18th Nov 20207:00 amRNSSARS-CoV-2 Inhibition by Graphene / Metal Oxides
21st Oct 202012:00 pmRNSResult of GM
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:35 pmRNSPrice Monitoring Extension
16th Oct 20205:18 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSAdvisory Panel
24th Sep 202012:07 pmRNSResult of AGM
23rd Sep 20207:00 amRNSPosting of Annual Report
1st Sep 20207:00 amRNSNotice of AGM
17th Aug 20207:00 amRNSUpdate re. Innovate UK Loan Agreement
11th Aug 20207:00 amRNSPreliminary Results
3rd Aug 20207:00 amRNSLaunch of Graphene Enhanced Protective Face Mask
1st Jul 20207:01 amRNS£5 million Innovate UK Loan Agreement
1st Jul 20207:00 amRNSCorporate Update and Notice of Results
19th Jun 20207:00 amRNSAppointment of Non-executive Chairman
12th Jun 20209:41 amRNSInvestor Communication
4th Jun 202012:02 pmRNSPrice Monitoring Extension
19th May 202012:07 pmRNSSecond Price Monitoring Extn
19th May 202012:02 pmRNSPrice Monitoring Extension
18th May 20204:41 pmRNSSecond Price Monitoring Extn
18th May 20204:36 pmRNSPrice Monitoring Extension
28th Apr 202011:17 amRNS2-DTech awarded grant
23rd Apr 20207:00 amRNSRolls-Royce chooses to partner with GEIC & 2-DTech
15th Apr 20205:10 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSClarification: Sharing Agreement & China JV
2nd Apr 20203:32 pmRNSHolding(s) in Company
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.